AP
ABBV icon

Adero Partners’s AbbVie ABBV Stock Holding History

Adero Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$667K Buy
3,182
+413
+15% +$80.3K 0.04% 111
2024
Q4 		$492K Sell
2,769
-1,501
-35% -$276K 0.03% 124
2024
Q3 		$843K Buy
4,270
+246
+6% +$45.9K 0.06% 92
2024
Q2 		$690K Buy
4,024
+836
+26% +$138K 0.05% 101
2024
Q1 		$580K Buy
3,188
+254
+9% +$43.8K 0.04% 104
2023
Q4 		$455K Sell
2,934
-484
-14% -$70.6K 0.04% 118
2023
Q3 		$509K Buy
3,418
+534
+19% +$78.4K 0.05% 101
2023
Q2 		$389K Sell
2,884
-39
-1% -$5.72K 0.04% 115
2023
Q1 		$466K Sell
2,923
-256
-8% -$39.1K 0.05% 105
2022
Q4 		$514K Buy
3,179
+532
+20% +$81.6K 0.06% 95
2022
Q3 		$399K Sell
2,647
-604
-19% -$86.7K 0.05% 101
2022
Q2 		$495K Sell
3,251
-32
-1% -$4.89K 0.07% 88
2022
Q1 		$532K Sell
3,283
-716
-18% -$104K 0.08% 84
2021
Q4 		$541K Buy
3,999
+364
+10% +$43K 0.09% 89
2021
Q3 		$392K Buy
3,635
+134
+4% +$15.3K 0.07% 106
2021
Q2 		$394K Buy
3,501
+1,473
+73% +$166K 0.09% 98
2021
Q1 		$219K Buy
2,028
+30
+2% +$3.21K 0.1% 108
2020
Q4 		$214K Buy
+1,998
New +$192K 0.18% 73

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Adero Partners's ABBV Position: Q1 2025 in Review

Adero Partners increased its AbbVie (ABBV) stake by 15% in Q1 2025, buying an estimated $80.3K and bringing the position to 3,182 shares worth $667K. The position accounts for 0.04% of the portfolio, ranked #111.

Adero Partners first reported a position in ABBV in Q4 2020 and has held it in 18 quarters since. The position peaked at $843K in Q3 2024. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Adero Partners held 3,182 shares of AbbVie worth $667K as of Q1 2025.
  • Adero Partners bought 413 AbbVie shares in Q1 2025, an estimated $80.3K.
  • AbbVie made up 0.04% of Adero Partners's portfolio in Q1 2025, its #111 holding.
  • Adero Partners first reported a position in AbbVie in Q4 2020 and has held it in 18 quarters since.
  • Adero Partners's AbbVie position peaked at $843K in Q3 2024.
  • 3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Adero Partners's 13F filing for Q1 2025, filed 17 Apr 2025.